Overall, these results indicate that STRIP2 and IGF2BP3 promote NSCLC progression partially through TMBIM6, suggesting the STRIP2/IGF2BP3/TMBIM6 axis is critical to NSCLC pathogenesis and the prognosis of patients with NSCLC. The gene discussed is IGF2BP3; the disease is non-small cell lung carcinoma.